Comments

Geron

GERNNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$4.68
0.081.74%
At Close: -
$4.70
0.020.43%
After Hours: 7:12 PM EDT
15 minutes delayed
Geron (GERN) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$10.00
Lowest Price Target1
$4.50
Consensus Price Target1
$6.94

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

Geron (NASDAQ:GERN) Stock, Analyst Ratings, Price Targets, Forecasts

Geron Corp has a consensus price target of $6.94 based on the ratings of 9 analysts. The high is $10 issued by TD Cowen on April 29, 2024. The low is $4.5 issued by Baird on April 30, 2024. The 3 most-recent analyst ratings were released by Barclays, Barclays, and Stifel on June 11, 2024, June 10, 2024, and June 10, 2024, respectively. With an average price target of $8.33 between Barclays, Barclays, and Stifel, there's an implied 77.30% upside for Geron Corp from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Feb
1
Mar
1
1
Apr
0
0
0
0
May
3
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Barclays
Barclays
Stifel
Needham
Wedbush

1calculated from analyst ratings

Analyst Ratings for Geron

Buy NowGet Alert
06/11/2024Buy Now91.49%Barclays
Carter Gould
 → $9Initiates → OverweightGet Alert
06/10/2024Buy Now91.49%Barclays— → $9Initiates → OverweightGet Alert
06/10/2024Buy Now48.94%Stifel
Stephen Willey
$6 → $7MaintainsBuyGet Alert
06/07/2024Buy Now27.66%Needham
Gil Blum
$5 → $6MaintainsBuyGet Alert
06/07/2024Buy Now48.94%Wedbush
Robert Driscoll
$7 → $7ReiteratesOutperform → OutperformGet Alert
05/02/2024Buy Now6.38%Needham
Gil Blum
 → $5ReiteratesBuy → BuyGet Alert
04/30/2024Buy Now-4.26%Baird
Joel Beatty
 → $4.5DowngradeOutperform → NeutralGet Alert
04/29/2024Buy Now112.77%TD Cowen
Tara Bancroft
 → $10Initiates → BuyGet Alert
04/11/2024Buy Now6.38%Needham
Gil Blum
 → $5ReiteratesBuy → BuyGet Alert
04/10/2024Buy Now27.66%Wedbush
Robert Driscoll
 → $6ReiteratesOutperform → OutperformGet Alert
03/15/2024Buy Now27.66%Wedbush
Robert Driscoll
 → $6ReiteratesOutperform → OutperformGet Alert
03/15/2024Buy Now6.38%Needham
Gil Blum
$4 → $5MaintainsBuyGet Alert
03/15/2024Buy Now6.38%Goldman Sachs
Corinne Jenkins
$4 → $5MaintainsBuyGet Alert
03/13/2024Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
03/12/2024Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
03/04/2024Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
02/28/2024Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
09/12/2023Buy Now-14.89%Goldman Sachs
Corinne Jenkins
 → $4UpgradeNeutral → BuyGet Alert
08/29/2023Buy Now27.66%Wedbush
Robert Driscoll
 → $6ReiteratesOutperform → OutperformGet Alert
08/04/2023Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
06/05/2023Buy Now-14.89%Needham
Gil Blum
 → $4ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now27.66%Wedbush
Robert Driscoll
 → $6ReiteratesOutperform → OutperformGet Alert
04/21/2023Buy Now-14.89%Needham
Gil Blum
 → $4Reiterates → BuyGet Alert
03/28/2023Buy Now-36.17%Goldman Sachs
Corinne Jenkins
 → $3Initiates → NeutralGet Alert
03/20/2023Buy Now6.38%B. Riley Securities
Kalpit Patel
 → $5Reiterates → BuyGet Alert
03/17/2023Buy Now27.66%Wedbush
Robert Driscoll
 → $6Reiterates → OutperformGet Alert
03/17/2023Buy Now-14.89%Needham
Gil Blum
 → $4Reiterates → BuyGet Alert
01/09/2023Buy Now-14.89%Needham
Gil Blum
$3 → $4MaintainsBuyGet Alert
01/04/2023Buy Now27.66%Wedbush
Robert Driscoll
$5 → $6MaintainsOutperformGet Alert
10/28/2022Buy Now6.38%Wedbush
Robert Driscoll
 → $5Initiates → OutperformGet Alert
08/12/2022Buy Now-36.17%Needham
Gil Blum
$2 → $3MaintainsBuyGet Alert
07/28/2022Buy Now-14.89%B. Riley Securities
Kalpit Patel
 → $4Reinstates → BuyGet Alert
05/10/2022Buy Now-57.45%Needham
Gil Blum
$3 → $2MaintainsBuyGet Alert
11/02/2021Buy Now-14.89%Baird
Joel Beatty
—Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Geron (GERN) stock?

A

The latest price target for Geron (NASDAQ:GERN) was reported by Barclays on June 11, 2024. The analyst firm set a price target for $9.00 expecting GERN to rise to within 12 months (a possible 91.49% upside). 20 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Geron (GERN)?

A

The latest analyst rating for Geron (NASDAQ:GERN) was provided by Barclays, and Geron initiated their overweight rating.

Q

When was the last upgrade for Geron (GERN)?

A

The last upgrade for Geron Corp happened on September 12, 2023 when Goldman Sachs raised their price target to $4. Goldman Sachs previously had a neutral for Geron Corp.

Q

When was the last downgrade for Geron (GERN)?

A

The last downgrade for Geron Corp happened on April 30, 2024 when Baird changed their price target from N/A to $4.5 for Geron Corp.

Q

When is the next analyst rating going to be posted or updated for Geron (GERN)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Geron, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Geron was filed on June 11, 2024 so you should expect the next rating to be made available sometime around June 11, 2025.

Q

Is the Analyst Rating Geron (GERN) correct?

A

While ratings are subjective and will change, the latest Geron (GERN) rating was a initiated with a price target of $0.00 to $9.00. The current price Geron (GERN) is trading at is $4.70, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch